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Abstract
Background The treatment and management of hip frac-
ture poses a great challenge for clinicians in osteology and
surgery. The aim of this study is to compare the clinical
effectiveness of the percutaneous compression plate
(PCCP) versus proximal femoral nail anti-rotation (PFNA)
in the treatment of intertrochanteric fractures in elderly
patients.
Methods A prospective randomized study was carried out
from January 2008 to October 2011 involving 90 elderly
patients with intertrochanteric fractures (90 hips) who
underwent minimally invasive surgery using the PCCP or
PFNA. Evaluation variables, including operation time,
intra- and perioperative blood loss, duration of hospital
stay, incidence of postoperative complications, and final
clinical outcomes by the end of follow-up, were used to
compare the benefits of these two implants.
Results Among 90 subjects, 45 received PCCPs and 45
received PFNAs. The baseline characteristics of the two
groups were comparable. The median follow-up time was
16.9 months (12–24 months). In the PCCP group, the mean
operative time was 53 min (40–75 min), and the mean
intra- and perioperative blood losses were 100.7 ml
(60–150 ml) and 916 ml (433–1339 ml), respectively,
which were significantly lower than those in the PFNA
group. Nevertheless, there was no statistical difference in
the incidence of postoperative complications and final
clinical outcomes including pain complaints, range of
motion of the hip, postoperative hip function at 12 months,
and the recovery of walking ability to pre-injury status
between these two implants.
Conclusions Overall, the PCCP and PFNA appear to have
similar clinical effects in treating elderly patients with
intertrochanteric fractures, although the PCCP provided
shorter operation times and less blood loss than PFNA.
Both implants discussed were demonstrated to be ideal for
the treatment of femoral intertrochanteric fractures in
elderly patients.
Introduction
Fracture of the proximal femur, generally termed ‘‘hip
fracture,’’ is one of the most common and severe fractures
occurring in the elderly population. It has been reported
that 90 % of hip fractures occur in patients over the age of
65 [1]. When compared with other fractures in this popu-
lation, hip fracture has greater associated rates of death and
disability as well as higher medical expenses [1, 2]. During
the last 25 years, the incidence of hip fracture has
increased rapidly, and it is estimated that 7.3–21.3 million
individuals will suffer from this injury globally in 2050 [3,
4]. Therefore, the treatment and management of hip frac-
ture pose great challenges for clinicians in osteology and
surgery.
The primary goal for the treatment of intertrochanteric
hip fracture is to achieve minimal mortality and morbidity,
low re-operation rates, and early successful run-up to sus-
tainable mobility. The basic strategy for achieving this goal
greatly depends on the quality of fracture fixation,
including biomechanical stability and rigidity [5, 6]. Cur-
rently, the sliding hip screw is the most widely used
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implant for fixation of intertrochanteric hip fracture and
thus serves as a benchmark in this field [7]. In elderly
patients, however, this surgical procedure is always asso-
ciated with substantial intra- and perioperative blood loss
and severe soft-tissue damage [8, 9]. Therefore, minimally
invasive surgical techniques are being developed in order
to overcome these problems implicit in sliding-screw fix-
ations [9]. The percutaneous compression plate (PCCP)
and proximal femoral nail anti-rotation (PFNA) are
recently developed devices designed for minimally inva-
sive surgery in the treatment of hip fractures, and they have
been widely used in elderly patients with demonstrated
clinical effectiveness [10–12]. Researchers have also per-
formed numerous clinical studies to compare either the
PCCP or PFNA with other orthopedic implants [13–16].
Nevertheless, reports on the clinical effectiveness of the
PCCP versus PFNA in elderly patients with intertrochan-
teric fractures are quite few.
In order to compare the clinical effects of the PCCP versus
PFNA in the treatment of hip fractures in elderly patients, we
conducted a prospective randomized study from January
2008 to October 2011 involving 90 elderly patients with
intertrochanteric fractures who underwent minimally inva-
sive surgery using the PCCP or PFNA. Evaluation variables,
including operation time and intra- and perioperative blood
loss, incidence of postoperative complications, and final
clinical outcomes at the end of follow-up, were used to
compare the benefits of these two implants.
Materials and methods
Patients
This study was approved by the Ethics Committee of the
authors’ institution. The inclusion criteria were: (1) being
older than 60 years (C60 years); (2) having intertrochanteric
fractures of type 31A1 and 31A2 based on the Orthopedic
Trauma Association (OTA) classification; (3) an American
Society of Anesthesiologists (ASA) Score of I-IV. The
exclusion criteria were: (1) younger than 60 years
(\60 years); (2) subtrochanteric fractures (type 31A3 in the
OTA classification); (3) an ASA score of V; (4) existing or
previous fractures in the same or contralateral hip; (5) inju-
ries that could affect the outcome measures; (6) abnormali-
ties that could affect the outcome measures. A total of 136
patients were assessed for eligibility between January 2008
and October 2009. Among them, 33 patients were excluded
on the basis of inclusion and exclusion criteria, and 13
refused to participate. Finally, 90 patients (90 hips) were
enrolled in this study (Fig. 1). Written informed consent was
obtained from each patient or the family members if the
patients were incapable of consent.
The patients were randomized into two groups,the PCCP
(n = 45) or PFNA (n = 45), using a sealed-envelope
system. The baseline characteristics, including age, gender,
cause of fracture, ASA risk score, OTA classification,
fracture type based on the Evans-Jensen classification
(types I and II as stable and types III–V as unstable),
comorbidities, and pre-injury walking ability score (0–9
points according to Parker and Palmer’s method [17]), are
described in Table 1.
Methods
For all patients in both treatment groups, PCCP or PFNA
operations were generally performed according to the
standard protocols provided by the manufacturer and the
procedures described in the previous literature [10, 12, 18,
19]. The PCCP implant (Orthofix Orthopedics Interna-
tional, Bussolengo, Italy) used in this study is composed of
a 125-mm plate, two neck screws with lengths from 90 to
140 mm in 10-mm increments, and three shaft screws with
lengths from 31 to 43 mm in 3-mm increments (Fig. 2a).
The PFNA implant (Synthes Inc., West Chester, PA, USA)
was a solid titanium nail with a length of 170 or 240 mm
(Fig. 2b). Both the PCCP and PFNA were inserted using a
percutaneous technique.
In order to make the operating procedures comparable
between the two groups, all operations were performed by
expert surgeons who had equal levels of experience with
both the PCCP and PFNA. Regional anesthesia was used
for both groups. Preoperative antibiotics were administered
intravenously to the patients in order to reduce the risk of
postoperative infections. All patients underwent implanta-
tion on a traction table in a supine position. Blood pressure,
pulse, respiration, body temperature, and blood oxygen
saturation were monitored during the operation. The
operative time was recorded from the start of the skin
incision to the time that skin closure was performed by a
nurse. Intraoperative blood loss was measured by collec-
tion of the suction volume and change in the weight (wet
vs. dry) of the sponges. No drains were used. Perioperative
blood loss was calculated based on the hemoglobin level
and the estimated blood volume of the patient, using the
method described by Foss and Kehlet [20]. Estimated
blood volume was determined according to gender, body
weight, and height [21].
On the first day after surgery, plain anteroposterior (AP)
and lateral radiographs were taken to evaluate the reduction
of fracture and the position of the PCCP or PFNA implants.
All patients were administered prophylactic antibiotics for
3 days. Under the guidance of surgeons, all patients were
encouraged to exercise their hip, knee, and ankle joints
from the first day post-surgery. They also started to walk
with full weight-bearing with a walking aid as soon as
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possible. For all patients, rivaroxaban (Xarelto, 10 mg/day,
p.o.) was administered for 5 weeks after surgery.
Follow-up was conducted in all patients at 3, 6, 9, and
12 months postoperatively and yearly thereafter. Plain AP
and lateral radiographs, complications, symptomatic com-
plaints about hip and thigh pain, the range of motion of the
hip, Oxford hip score (OHS), and Harris hip score (HHS) at
12 months post-surgery [22, 23] as well as the walking
ability score were recorded.
Statistical analysis
The sample size of this study was calculated based on the
OHS at 12 months postoperatively because the OHS at
12 months post-surgery is an important and validated
variable in determining clinical outcomes [24]. The cal-
culation was performed according to the results of a pilot
study. In this pilot study, the means and standard deviations
(SD) of the OHS at 12 months post-surgery in PCCP and
PFNA groups was 23.1 ± 3.8 and 25.6 ± 4.3, respec-
tively. Our hypothesis was that there would be a significant
difference in the OHS at 12 months post-surgery between
the two groups. This requires at least 34 subjects per group
with 80 % power (1 - b) at the 0.1 significance level (a)
for statistical analysis, which was calculated using PASS
2008 software (NCSS LLC, Kaysville, UT, USA).
Assuming an approximate dropout rate of 20 %, at least 41
subjects were needed for each group. In order to avoid
under-powering due to an incorrect estimate of (1 - b) and
a, we decided to recruit 45 subjects per group in this study.
The statistical analysis was performed with SPSS 12.0
software (SPSS Inc, Chicago, IL, USA). All quantitative
variables were tested for normality distribution using the
Kolmogorov-Smirnov test and presented as mean (SD).
Statistical significance of quantitative variables between
groups was assessed by Student’s t test for independent
samples. Statistical significance of categorical variables
was assessed by the chi-square test or Fisher’s exact test. A
value of p \ 0.05 was considered significant (two-tailed).
Results
The baseline data of patients, including age, gender dis-
tribution, ASA score, and fracture types, were comparable
between the two treatment groups. According to the Evans
Fig. 1 Flow chart of the
enrollment of patients for the
percutaneous compression plate
(PCCP) and proximal femoral
nail anti-rotation (PFNA)
groups
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and Jensen classification, unstable fractures occurred in 49
hips and stable fractures occurred in 41 hips. In addition,
the majority of patients in both groups had comorbidity
with cardiovascular or metabolic disorders (Table 1).
Intra- and perioperative clinical data
The intra- and perioperative data of the PCCP and PFNA
groups are shown in Table 2. All operations were performed
by experienced surgeons in our department. The mean PFNA
surgery duration was approximately 70 min, which was
notably longer than that of PCCP (p \ 0.0001). Addition-
ally, the intraoperative and calculated perioperative blood
loss of patients between the two groups was also significantly
different (p \ 0.0001). Patients receiving PFNA had more
blood loss than those receiving PCCP (138.2 vs. 100.7 ml in
the mean intraoperative blood loss and 1111 vs. 916 ml in the
mean perioperative blood loss, respectively). For the dura-
tion of the hospital stay, there was no statistical difference
between the PCCP and PFNA groups (7.4 vs. 8.2 days in
mean hospital stay) (p = 0.3412).
Postoperative complications by the end of follow-up
Follow-up was obtained from all patients with a median
follow-up time of 16.9 months (12–24 months). No patient
was lost to follow-up, and no deaths occurred in either
group. Data regarding postoperative complications by the
end of follow-up are listed in Table 3. Statistical analysis
demonstrated that there was no significant difference in
Table 1 The baseline
characteristics of enrolled
patients
PCCP percutaneous
compression plate, PFNA
proximal femoral nail anti-
rotation, SD standard deviation,
ASA American Society of
Anesthesiologists, OTA
Orthopedic Trauma Association
PCCP PFNA Difference of
means (95 % CI)
p value
Total number of patients 45 45
Age, years
Range 63–92 67–89
Mean (SD) 71.6 (7.5) 74.2 (8.8) 2.6 (-0.83 to 6.0) 0.1350
Gender 0.6657
Male 16 19
Female 29 26
Causes of fracture 0.1999
Slip injury 32 24
Traffic injury 9 15
Fall injury 4 4
Others 0 2
ASA risk score 0.9077
I 6 7
II 13 12
III 19 21
IV 7 5
OTA fracture classification 0.5248
31A1 18 22
31A2 27 23
Fracture type 0.3974
Stable 23 18
Unstable 22 27
Comorbidity
Hypertension and cardiovascular diseases 33 35
Diabetes mellitus 16 19
Osteoporosis 5 7
Sequelae of cerebral infarction 2 2
Pulmonary infection 2 3
Chronic renal insufficiency 1 0
Pre-injury walking ability score
Range 6–10 6–10
Mean (SD) 7.4 (2.9) 7.6 (2.3) 0.2 (-0.9 to 1.3) 0.7179
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postoperative complications between the PCCP and PFNA
groups. However, it should be noted that one patient in the
PFNA group suffered a femoral shaft fracture, which may
have been due to stress concentration. This case was
carefully treated with conservative treatment, and full
weight-bearing was delayed for 6–8 weeks. After
12 months, the femoral shaft fracture in this patient was
healing very well. Additionally, two patients in the PFNA
group suffered from fat embolism syndrome (FES). Both
patients developed the associated clinical manifestations,
including tachypnea, dyspnea, drowsiness, and a nonpap-
pable petechial rash in the chest, axilla, conjunctiva, and
neck on the second day after surgery. After receiving high-
flow oxygen inhalation as well as albumin and steroid
therapy, these clinical manifestations gradually faded.
Clinical outcomes by the end of follow-up
Clinical outcomes of patients in both treatment groups are
presented in Table 4. No complications related to fracture
union occurred during the follow-up period. All patients
achieved clinical and radiological union by the end of
follow-up. Symptomatic complaints included hip and thigh
pain in 22 patients from the PCCP and PFNA groups
during the follow-up period. Nevertheless, statistical ana-
lysis revealed that there was no difference in the rate of
pain complaints between these two groups. Hip flexion was
also similar among the patients treated with the two dif-
ferent implants. Additionally, the mean OHSs were 22.8
and 24.0 for the PCCP and PFNA group, respectively. For
HHS, ‘‘excellent’’ and ‘‘good’’ results were achieved in
Table 2 Intra- and
perioperative clinical data
PCCP percutaneous
compression plate, PFNA
proximal femoral nail anti-
rotation, SD standard deviation,
CI confidence interval
PCCP PFNA Difference of
means (95 % CI)
p value
Operation time (min)
Range 40–75 43–116
Mean (SD) 53.0 (9.4) 66.5 (18.1) 13.5 (7.4 to 19.6) \0.0001
Intraoperative blood loss (ml)
Range 60–150 65–250
Mean (SD) 100.7 (23.5) 138.2 (51.8) 37.5 (20.4 to 54.6) \0.0001
Calculated perioperative blood loss (ml)
Range 433–1339 634–1651
Mean (SD) 916 (44) 1111 (42) 195 (177–213) \0.0001
Hospital stay (days)
Range 6–14 5–19
Mean (SD) 7.4 (3.6) 8.2 (4.3) 0.8 (-0.86 to 2.5) 0.3412
Fig. 2 Pictures of the
percutaneous compression plate
(PCCP) and proximal femoral
nail anti-rotation (PFNA) used
in this study. a The PCCP
implant, manufactured by
Orthofix Orthopedics
International (Via delle Nazioni
9, Bussolengo, Italy); b the
PFNA implant (length 170 or
240 mm), manufactured by
Synthes Inc. (1302 Wrights
Lane East, West Chester, PA,
USA)
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77.8 % of patients in the PCCP group (35/45) and 82.2 %
in the PFNA group (37/45) at 12 months postoperatively.
These results indicate that lost hip function was regained in
most patients within the first year after implant surgery.
Walking ability was also improved to pre-injury status in
58.9 % of all patients in the treatment groups (26 in the
PCCP group and 27 in the PFNA group, respectively).
However, no statistical significance was observed between
these two groups in terms of OHS, HHS, and walking
ability score.
Typical cases
Case 1
A 92-year-old female patient was diagnosed with a left
femur intertrochanteric fracture (31-A2.3) (Fig. 3a). The
comorbidities were severe osteoporosis, coronary arterio-
sclerotic heart disease (chronic myocardial ischemia and
frequent premature ventricular contractions), stage III
hypertension, and stage IV chronic kidney disease. She
underwent a PCCP operation lasting 55 min and experi-
enced 80 ml intraoperative blood loss. After surgery, the
X-ray radiograph showed that anatomic reduction of the
fracture had been achieved through appropriate positioning
of the plate (Fig. 3b). One week after surgery, this patient
was able to walk with a walking aid. Function of the hip
joint was greatly improved at 12 months postoperatively
with an OHS of 19 and an ‘‘excellent’’ HHS of 91.
Case 2
A 75-year-old female patient was diagnosed with a right
femoral intertrochanteric fracture (31-A2.2) (Fig. 3c). She
had comorbidity with diabetes mellitus and stage III
hypertension. PFNA surgery was performed over a 70-min
period, and intraoperative blood loss was 110 ml. After
surgery, the X-ray radiograph showed the near-anatomic
reduction of the fracture had been achieved (Fig. 3d).
Postoperative joint function was restored with an OHS of
Table 3 Postoperative complications for the PCCP and PFNA
groups
Complications PCCP PFNA p value
General complications
Cardiac failure 2 1 0.6077
Pneumonia 1 1 1.0000
Cerebral infarction 2 3 1.0000
Urinary tract infection 1 0 0.4828
Deep venous thrombosis 2 1 0.6077
Urosepsis 1 0 0.4828
Local complications
Femoral shaft fracture 0 1 1.000
Hematoma 0 1 1.0000
Fat embolism syndrome 0 2 0.4948
Superficial wound infection 1 0 0.4828
PCCP percutaneous compression plate, PFNA proximal femoral nail
anti-rotation
Table 4 Clinical outcomes by
the end of follow-up
PCCP percutaneous
compression plate, PFNA
proximal femoral nail anti-
rotation, SD standard deviation,
CI confidence interval, OHS
Oxford hip score, HHS Harris
hip score
PCCP PFNA Difference of
means (95 % CI)
p value
Hip pain 5 7 0.7578
Thigh pain 4 6 0.7391
Hip flexion
Range 71–132 69–131
Mean (SD) 96.1 (15.1) 97.5 (15.0) 1.4 (-5.0 to 7.8) 0.6657
OHS at 12 months postoperatively
Range 12–35 12–37
Mean (SD) 22.8 ± 7.0 24.0 ± 7.2 1.2 (-1.8 to 4.2) 0.4249
HHS at 12 months postoperatively
Excellent/good/fair/poor 24/11/10/0 23/14/8/0 0.7395
Range 70–100 67–100
Mean (SD) 88.4 (9.0) 87.6 (8.4) -0.8 (-4.4 to 2.8) 0.6640
Walking ability score
Range 5–10 5–10
Mean (SD) 6.9 (1.5) 6.7 (2.8) -0.2 (-1.1 to 0.74) 0.6738
Recovery of walking ability to pre-injury status 1.0000
Yes 26 27
No 19 18
982 Q. Guo et al.
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17 and an ‘‘excellent’’ HHS of 95 at 12 months
postoperatively.
Discussion
The treatment of femoral intertrochanteric fracture in
elderly patients remains challenging because these patients
always have severe comorbidities, resulting in long hos-
pitalizations and multiple postoperative complications with
a high mortality rate [18, 19]. Therefore, internal fixation is
usually recommended in the clinic in order to reduce
mortality as well as the incidence of coxa vara and limb
shortening [25]. Traditional internal fixation has many
disadvantages, such as a large wound, heavy blood loss,
severe pain, a high incidence of postoperative complica-
tions, and slow functional recovery [26, 27]. Minimally
invasive surgical techniques for hip fracture are able to
overcome these drawbacks. The PCCP and PFNA, the
minimally invasive implants most frequently used for
Fig. 3 Pre- and postoperative
radiographs of representative
cases. a, b A case in the
percutaneous compression plate
(PCCP) group: b reduction and
fixation of the fracture were
achieved. c, d A case in the
proximal femoral nail anti-
rotation (PFNA) group; d the
fracture was reduced after
receiving a PFNA
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internal fixation in current traumatic orthopedics, have
been widely accepted for use in the treatment of femoral
intertrochanteric fracture in elderly cases [8, 9]. To our
knowledge, however, there has been no literature published
regarding the comparison between these two implants. In
this study, the results showed that there was no obvious
difference in the clinical outcomes of patients receiving
PCCP and PFNA, except for the surgery duration and intra-
and perioperative blood loss.
A percutaneous compression plate was first reported for
clinical application by Gotfried in 2000 [18]. This implant
is a device with a double-axis and two parallel femoral
neck screws, which can withstand high rotational force and
provide rotational stability. The small diameter of the
screw protects the lateral cortex, thus effectively prevent-
ing fracture displacement and allowing immediate full
weight-bearing [28]. Comparatively, PFNA has a special
helical blade design, which is developed on the basis of the
proximal femoral nail (PFN). This special blade has a large
surface and increasing core diameter, which guarantees
maximum compaction and optimal hold in the bone.
Increased rotational and angular stability caused by bone
compaction around the PFNA blade can effectively avoid
rotation and varus collapse, which has been biomechani-
cally proven [29]. Therefore, generally, both the PCCP and
PFNA have desirable mechanical properties for internal
fixation of hip fractures. However, in regards to surgical
duration and intra- and perioperative blood loss, our results
showed there was a significant difference between these
two implants. Patients in the PFNA group underwent
longer operation times and lost more blood during surgery
compared to the PCCP group. This might be attributed to
the procedures necessary for femur opening and insertion
of the PFNA implant into the medullary canal, which
requires much care and time to succeed in correctly posi-
tioning the implant in the medullary canal.
Our clinical outcome results showed that postoperative
complications were well controlled in both groups and that
there was no significant difference in the incidence of
postoperative complications between PCCP and PFNA.
Furthermore, we did not observe any complications related
to fracture union during the follow-up period, which can
perhaps be attributed to the extensive experience of the
surgeons involved in this study as well as strict postoper-
ative patient management. These findings are also consis-
tent with the results reported in previous studies [16, 30],
which report a very low incidence of complications related
to fracture union in patients receiving the PCCP or PFNA.
Nevertheless, one patient with the PFNA did encounter
femoral shaft fracture at the tip of the implant. This com-
plication has been reported to be common when using
intramedullary nails for treating proximal femoral frac-
tures. Leung et al. [31] reported a geometric distinction in
Gamma nails used in Chinese patients because elderly
Chinese have relatively shorter femurs and excessive
anterior bowing as compared to American and European
patients. The case of femoral shaft fracture in our study
also involved a short femur. When the PFNA implant was
inserted, the stem likely did not fit the patient’s femur well,
thus causing the malposition of the implant in the medul-
lary canal. Additionally, a wedge effect may occur during
the introduction process involving the use of a hammer.
The malpositioning of the PFNA and the wedge effect
produced a stress concentration, thus resulting in the
occurrence of femoral shaft fracture in this case.
It should be noted that two patients in the PFNA group
developed FES right after surgery. The pathophysiology of
FES remains unclear, although two theories, mechanical
and biochemical, currently exist, which postulate its
occurrence [32]. Previous literature has pointed out that
FES is commonly associated with traumatic fracture of the
femur, pelvis, or tibia [33]. In addition, there may be a
casual correlation between FES onset and intramedullary
nailing, and pelvic and knee arthroplasty, although there is
much controversy surrounding this issue [32]. In the cur-
rent study, FES only occurred in the patients receiving
PFNA, indicating intramedullary fixation with PFNA
might be responsible for its onset. However, further study
with a large population is needed to verify this assumption.
Researchers have reported that hip and thigh pain is
common, with treatment involving intramedullary fixation
[34]. However, our results show that the incidence of hip
and thigh pain was relatively lower in both groups when
compared with the results reported in previous literature
[34]. As to the recovery of hip function and walking ability,
there was no significant difference between these two
devices. Between both groups, walking ability was recov-
ered to pre-injury status in 58.9 % of patients, which is
close to or even higher than the results reported in other
literature [34, 35]. This finding indicates that the selection
of the PCCP or PFNA as the implant for fixation is not a
key determinant of clinical outcomes. General conditions
of patients, postoperative exercises, and the multidisci-
plinary management of preoperative comorbidities and
postoperative complications may determine the final out-
comes of patients.
Numerous studies have been performed to compare the
clinical effect and safety of the PCCP with the dynamic hip
screw (DHS), which has been considered as the gold
standard treatment for intertrochanteric fracture [26]. As a
minimally invasive implant, the PCCP has obvious
advantages in regards to blood loss, need for transfusions,
and systematic complications, although it was shown to be
similar to the DHS in mechanical stability and clinical
effect [8, 9]. Furthermore, increasingly surgeons are not
considering the PFNA a truly minimally invasive technique
984 Q. Guo et al.
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because of the potential risk of femoral shaft fracture, more
severe tissue damage, and greater blood loss [6]. According
to our experience, although the PFNA has the aforemen-
tioned disadvantages, they can be easily controlled. Addi-
tionally, this device has a broader range of applications
than PCCP. For example, it can be used for treating 31A3
fractures, which is a contraindication for the PCCP. More
importantly, insertion of the PFNA is able to compact the
cancellous bone, providing additional anchoring, which is
especially suitable for patients with osteoporotic bone.
In summary, based on our findings, the PCCP and PFNA
appeared to have similar clinical effects in treating elderly
patients with intertrochanteric fractures. The PCCP was
shown to require shorter operation times and less blood
loss than the PFNA. However, both were demonstrated to
be ideal implants for the treatment of femoral intertro-
chanteric fractures, especially those that occur in elderly
patients with severe pre-existing diseases.
Acknowledgments We thank Dr. Xiankai Huang for his profes-
sional assistance in data collection and analysis.
Conflict of interest The authors declare that they have no conflict
of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Braithwaite RS, Col NF, Wong JB. Estimating hip fracture
morbidity, mortality and costs. J Am Geriatr Soc.
2003;51:364–70.
2. Zethraeus N, Gerdtham UG. Estimating the costs of hip fracture
and potential savings. Int J Technol Assess Health Care.
1998;14:255–67.
3. Johnell O, Kanis JA. An estimate of the worldwide prevalence
and disability associated with osteoporotic fractures. Osteoporos
Int. 2006;17:1726–33.
4. Cumming RG, Nevitt MC, Cummings SR. Epidemiology of hip
fractures. Epidemiol Rev. 1997;19:244–57.
5. Baumgaertner MR, Curtin SL, Lindskog DM. Intramedullary
versus extramedullary fixation for the treatment of intertrochan-
teric hip fractures. Clin Orthop Relat Res. 1998;348:87–94.
6. Gardenbroek TJ, Segers MJ, Simmermacher RK, Hammacher
ER. The proximal femur nail antirotation: an identifiable
improvement in the treatment of unstable pertrochanteric frac-
tures? J Trauma. 2011;71:169–74.
7. Schipper IB, Marti RK, van der Werken C. Unstable trochanteric
femoral fractures: extramedullary or intramedullary fixation.
Review of literature. Injury. 2004;35:142–51.
8. Zhou Z, Zhang X, Tian S, Wu Y. Minimally invasive versus
conventional dynamic hip screw for the treatment of intertro-
chanteric fractures in older patients. Orthopedics. 2012;35:
e244–9.
9. Cheng T, Zhang G, Zhang X. Review: minimally invasive versus
conventional dynamic hip screw fixation in elderly patients with
intertrochanteric fractures: a systematic review and meta-ana-
lysis. Surg Innov. 2011;18:99–105.
10. Bensafi H, Laffosse JM, Giordano G, Dao C, Chiron P, Puget J.
The percutaneous compression plate (PCCP) in the treatment of
trochanteric hip fractures in elderly patients. Acta Orthop Belg.
2006;72:314–9.
11. Yang E, DeLaMora S. Minimally invasive treatment of inter-
trochanteric hip fractures with the Gotfried percutaneous com-
pression plate. Orthopedics. 2008;31:29–36.
12. Pu JS, Liu L, Wang GL, Fang Y, Yang TF. Results of the
proximal femoral nail anti-rotation (PFNA) in elderly Chinese
patients. Int Orthop. 2009;33:1441–4.
13. Panesar SS, Mirza S, Bharadwaj G, Woolf V, Ravikumar R, A-
thanasiou T. The percutaneous compression plate versus the
dynamic hip screw: a meta-analysis. Acta Orthop Belg.
2008;74:38–48.
14. Cheng T, Zhang GY, Liu T, Zhang XL. A meta-analysis of
percutaneous compression plate versus sliding hip screw for the
management of intertrochanteric fractures of the hip. J Trauma
Acute Care Surg. 2012;72:1435–43.
15. Zhou F, Zhang ZS, Yang H, Tian Y, Ji HQ, Guo Y, et al. Less
invasive stabilization system (LISS) versus proximal femoral nail
anti-rotation (PFNA) in treating proximal femoral fractures: a
prospective randomized study. J Orthop Trauma.
2012;26:155–62.
16. Yaozeng X, Dechun G, Huilin Y, Guangming Z, Xianbin W.
Comparative study of trochanteric fracture treated with the
proximal femoral nail anti-rotation and the third generation of
gamma nail. Injury. 2010;41:1234–8.
17. Parker MJ, Palmer CR. A new mobility score for predicting
mortality after hip fracture. J Bone Joint Surg Br. 1993;75:797–8.
18. Gotfried Y. Percutaneous compression plating of intertrochan-
teric hip fractures. J Orthop Trauma. 2000;14:490–5.
19. Gotfried Y. Percutaneous compression plating for intertrochan-
teric hip fractures: treatment rationale. Orthopedics.
2002;25:647–52.
20. Foss NB, Kehlet H. Hidden blood loss after surgery for hip
fracture. J Bone Joint Surg Br. 2006;88:1053–9.
21. Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in
normal human adults. Surgery. 1962;51:224–32.
22. Fitzpatrick R, Morris R, Hajat S, Reeves B, Murray DW, Hannen
D, et al. The value of short and simple measures to assess out-
comes for patients of total hip replacement surgery. Qual Health
Care. 2000;9:146–50.
23. Mahomed NN, Arndt DC, McGrory BJ, Harris WH. The Harris
hip score: comparison of patient self-report with surgeon
assessment. J Arthroplasty. 2001;16:575–80.
24. Wamper KE, Sierevelt IN, Poolman RW, Bhandari M, Haverk-
amp D. The Harris hip score: do ceiling effects limit its useful-
ness in orthopedics? Acta Orthop. 2010;81:703–7.
25. White JJ, Khan WS, Smitham PJ. Perioperative implications of
surgery in elderly patients with hip fractures: an evidence-based
review. J Perioper Pract. 2011;21:192–7.
26. Parker MJ, Gurusamy K. Modern methods of treating hip frac-
tures. Disabil Rehabil. 2005;27:1045–51.
27. Smith TO, Blake V, Hing CB. Minimally invasive versus con-
ventional exposure for total hip arthroplasty: a systematic review
and meta-analysis of clinical and radiological outcomes. Int
Orthop. 2011;35:173–84.
28. Hughson J, Newman J, Pendleton RC. Hip fracture management
for the hospital-based clinician: a review of the evidence and best
practices. Hosp Pract (Minneap). 2011;39:52–61.
29. Strauss E, Frank J, Lee J, Kummer FJ, Tejwani N. Helical blade
versus sliding hip screw for treatment of unstable intertrochan-
teric hip fractures: a biomechanical evaluation. Injury. 2006;37:
984–9.
PCCP vs. PFNA for hip fracture 985
123
30. Peyser A, Weil Y, Brocke L, Manor O, Mosheiff R, Liebergall M.
Percutaneous compression plating versus compression hip screw
fixation for the treatment of intertrochanteric hip fractures. Injury.
2005;36:1343–9.
31. Leung KS, Procter P, Robioneck B, Behrens K. Geometric mis-
match of the Gamma nail to the Chinese femur. Clin Orthop Relat
Res. 1996;323:42–8.
32. Parisi DM, Koval K, Egol K. Fat embolism syndrome. Am J
Orthop (Belle Mead NJ). 2002;31:507–12.
33. Shaikh N. Emergency management of fat embolism syndrome.
J Emerg Trauma Shock. 2009;2:29–33.
34. Utrilla AL, Reig JS, Munoz FM, Tufanisco CB. Trochanteric
gamma nail and compression hip screw for trochanteric fractures:
a randomized, prospective, comparative study in 210 elderly
patients with a new design of the gamma nail. J Orthop Trauma.
2005;19:229–33.
35. Suckel AA, Dietz K, Wuelker N, Helwig P. Evaluation of com-
plications of three different types of proximal extra-articular
femur fractures: differences in complications, age, sex and sur-
viving rates. Int Orthop. 2007;31:689–95.
986 Q. Guo et al.
123
